Teleflex Inc (TFX)
210.66
-3.78
(-1.76%)
USD |
NYSE |
Apr 15, 16:00
210.50
-0.16
(-0.08%)
After-Hours: 20:00
Teleflex Enterprise Value: 11.51B for April 15, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| April 15, 2024 | 11.51B |
| April 12, 2024 | 11.68B |
| April 11, 2024 | 11.82B |
| April 10, 2024 | 11.86B |
| April 09, 2024 | 12.12B |
| April 08, 2024 | 11.80B |
| April 05, 2024 | 11.79B |
| April 04, 2024 | 11.56B |
| April 03, 2024 | 11.70B |
| April 02, 2024 | 11.82B |
| April 01, 2024 | 12.08B |
| March 28, 2024 | 12.23B |
| March 27, 2024 | 12.13B |
| March 26, 2024 | 11.77B |
| March 25, 2024 | 11.93B |
| March 22, 2024 | 11.99B |
| March 21, 2024 | 12.15B |
| March 20, 2024 | 11.97B |
| March 19, 2024 | 11.85B |
| March 18, 2024 | 11.78B |
| March 15, 2024 | 11.73B |
| March 14, 2024 | 11.86B |
| March 13, 2024 | 12.05B |
| March 12, 2024 | 12.25B |
| March 11, 2024 | 12.28B |
| Date | Value |
|---|---|
| March 08, 2024 | 12.15B |
| March 07, 2024 | 12.36B |
| March 06, 2024 | 12.16B |
| March 05, 2024 | 12.10B |
| March 04, 2024 | 12.18B |
| March 01, 2024 | 12.09B |
| February 29, 2024 | 12.08B |
| February 28, 2024 | 12.17B |
| February 27, 2024 | 12.23B |
| February 26, 2024 | 12.31B |
| February 23, 2024 | 12.78B |
| February 22, 2024 | 12.78B |
| February 21, 2024 | 13.40B |
| February 20, 2024 | 13.40B |
| February 16, 2024 | 13.40B |
| February 15, 2024 | 13.59B |
| February 14, 2024 | 13.31B |
| February 13, 2024 | 13.26B |
| February 12, 2024 | 13.48B |
| February 09, 2024 | 13.45B |
| February 08, 2024 | 13.41B |
| February 07, 2024 | 13.39B |
| February 06, 2024 | 13.46B |
| February 05, 2024 | 13.07B |
| February 02, 2024 | 13.15B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
9.586B
Minimum
Oct 27 2023
22.80B
Maximum
Apr 28 2021
16.14B
Average
16.94B
Median
Enterprise Value Benchmarks
| Stryker Corp | 138.90B |
| Masimo Corp | 8.044B |
| NeuroMetrix Inc | -11.00M |
| Insulet Corp | 12.87B |
| Tandem Diabetes Care Inc | 1.908B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | 31.10M |
| Revenue (Quarterly) | 773.91M |
| Total Expenses (Quarterly) | 639.00M |
| EPS Diluted (Quarterly) | 0.66 |
| Gross Profit Margin (Quarterly) | 55.75% |
| Profit Margin (Quarterly) | 4.02% |
| Earnings Yield | 3.57% |
| Operating Earnings Yield | 5.65% |
| Normalized Earnings Yield | 4.033 |